3,100
Views
11
CrossRef citations to date
0
Altmetric
Articles

Are illness perceptions, beliefs about medicines and Type D personality associated with medication adherence among thyroid cancer survivors? A study from the population-based PROFILES registry

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, & ORCID Icon show all
Pages 128-143 | Received 07 Apr 2017, Accepted 11 May 2019, Published online: 25 May 2019

References

  • Alison Phillips, L., Leventhal, H., & Leventhal, E. A. (2013). Assessing theoretical predictors of long-term medication adherence: Patients' treatment-related beliefs, experiential feedback and habit development. Psychology & Health, 28, 1135–1151. doi:10.1080/08870446.2013.793798
  • Axelsson, M. (2013). Personality and reasons for not using asthma medication in young adults. Heart Lung, 42, 241–246. doi:10.1016/j.hrtlng.2013.01.005
  • Biondi, B., & Cooper, D. S. (2008). The clinical significance of subclinical thyroid dysfunction. Endocrine Reviews, 29(1), 76–131. doi:10.1210/er.2006-0043
  • Bolman, C., Arwert, T. G., & Vollink, T. (2011). Adherence to prophylactic asthma medication: Habit strength and cognitions. Heart Lung, 40(1), 63–75. doi:10.1016/j.hrtlng.2010.02.003
  • Boons, C., Timmers, L., van Schoor, N. M., Swart, E. L., Hendrikse, N. H., Janssen, J., & Hugtenburg, J. G. (2017). Patient satisfaction with information on oral anticancer agent use. Cancer Med. doi:10.1002/cam4.1239
  • Broadbent, E., Petrie, K. J., Main, J., & Weinman, J. (2006). The brief illness perception questionnaire. Journal of Psychosomatic Research, 60, 631–637. doi:10.1016/j.jpsychores.2005.10.020
  • Brostrom, A., Stromberg, A., Martensson, J., Ulander, M., Harder, L., & Svanborg, E. (2007). Association of Type D personality to perceived side effects and adherence in CPAP-treated patients with OSAS. Journal of Sleep Research, 16, 439–447. doi:10.1111/j.1365-2869.2007.00620.x
  • Corter, A. L., Findlay, M., Broom, R., Porter, D., & Petrie, K. J. (2013). Beliefs about medicine and illness are associated with fear of cancer recurrence in women taking adjuvant endocrine therapy for breast cancer. British Journal of Health Psychology, 18(1), 168–181. doi:10.1111/bjhp.12003
  • Crilly, M. (2004). Thyroxine adherence in primary hypothyroidism. Lancet, 363, 1558. doi:10.1016/S0140-6736(04)16172-2
  • Davies, L., & Welch, H. G. (2006). Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA, 295, 2164–2167. doi:10.1001/jama.295.18.2164
  • de Raaij, E. J., Schroder, C., Maissan, F. J., Pool, J. J., & Wittink, H. (2012). Cross-cultural adaptation and measurement properties of the brief illness perception questionnaire-Dutch language version. Manual Therapy, 17, 330–335. doi:10.1016/j.math.2012.03.001
  • de Vries, S. T., Keers, J. C., Visser, R., de Zeeuw, D., Haaijer-Ruskamp, F. M., Voorham, J., & Denig, P. (2014). Medication beliefs, treatment complexity, and non-adherence to different drug classes in patients with type 2 diabetes. Journal of Psychosomatic Research, 76, 134–138. doi:10.1016/j.jpsychores.2013.11.003
  • Denollet, J. (2005). DS14: Standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosomatic Medicine, 67(1), 89–97. doi:10.1097/01.psy.0000149256.81953.49
  • Denollet, J., Schiffer, A. A., & Spek, V. (2010). A general propensity to psychological distress affects cardiovascular outcomes: Evidence from research on the type D (distressed) personality profile. Circulation: Cardiovascular Quality and Outcomes, 3, 546–557. doi:10.1161/CIRCOUTCOMES.109.934406
  • Dieltjens, M., Vanderveken, O. M., Van den Bosch, D., Wouters, K., Denollet, J., Verbraecken, J. A., … Braem, M. J. (2013). Impact of type D personality on adherence to oral appliance therapy for sleep-disordered breathing. Sleep Breath, 17, 985–991. doi:10.1007/s11325-012-0788-x
  • Ferlay, J., Shin, H. R., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer, 127, 2893–2917. doi:10.1002/ijc.25516
  • Hannemann, A., Friedrich, N., Haring, R., Krebs, A., Volzke, H., Alte, D., … Wallaschofski, H. (2010). Thyroid function tests in patients taking thyroid medication in Germany: Results from the population-based Study of Health in Pomerania (SHIP). BMC Research Notes, 3, 227. doi:10.1186/1756-0500-3-227
  • Horne, R., Chapman, S. C., Parham, R., Freemantle, N., Forbes, A., & Cooper, V. (2013). Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: A meta-analytic review of the Necessity-Concerns Framework. PLoS One, 8, e80633. doi:10.1371/journal.pone.0080633
  • Horne, R., & Weinman, J. (1999). Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. Journal of Psychosomatic Research, 47, 555–567.
  • Horne, R., Weinman, J., & Hankins, M. (1999). The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychology & Health, 14, 1–24. doi:10.1080/08870449908407311
  • Husson, O., Haak, H. R., Buffart, L. M., Nieuwlaat, W. A., Oranje, W. A., Mols, F., … van de Poll-Franse, L. V. (2013). Health-related quality of life and disease specific symptoms in long-term thyroid cancer survivors: A study from the population-based PROFILES registry. [Research Support, Non-U.S. Gov't]. Acta Oncologica, 52, 249–258. doi:10.3109/0284186X.2012.741326
  • Husson, O., Nieuwlaat, W. A., Oranje, W., Haak, H., van de Poll-Franse, L., & Mols, F. (2013). Fatigue among short- and long-term thyroid cancer survivors: Results from the population-based PROFILES registry. Thyroid. doi:10.1089/thy.2013.0015
  • Janssen-Heijnen, M. L. G., Louwman, W. J., van de Poll-Franse, L. V., & Coebergh, J. W. W. (2005). Results of 50 years cancer registry in the South of the Netherlands: 1955–2004 (in Dutch). Eindhoven: Eindhoven Cancer Registry.
  • Janz, N. K., & Becker, M. H. (1984). The Health Belief Model: A decade later. Health Education Quaterly, 11(1), 1–47. doi:10.1177/109019818401100101
  • Molloy, G. J., Randall, G., Wikman, A., Perkins-Porras, L., Messerli-Burgy, N., & Steptoe, A. (2012). Type D personality, self-efficacy, and medication adherence following an acute coronary syndrome. Psychosomatic Medicine, 74(1), 100–106. doi:10.1097/PSY.0b013e31823a5b2f
  • Mols, F., & Denollet, J. (2010a). Type D personality among noncardiovascular patient populations: A systematic review. General Hospital Psychiatry, 32(1), 66–72. doi:10.1016/j.genhosppsych.2009.09.010
  • Mols, F., & Denollet, J. (2010b). Type D personality in the general population: A systematic review of health status, mechanisms of disease, and work-related problems. Health and Quality of Life Outcomes, 8, 9. doi:10.1186/1477-7525-8-9
  • Morris, J. C. (2009). How do you approach the problem of TSH elevation in a patient on high-dose thyroid hormone replacement? Clinical Endocrinology, 70, 671–673. doi:10.1111/j.1365-2265.2009.03536.x
  • Morris, L. F., Waguespack, S. G., Warneke, C. L., Ryu, H., Ying, A. K., Anderson, B. J., … Perrier, N. D. (2012). Long-term follow-up data may help manage patient and parent expectations for pediatric patients undergoing thyroidectomy. Surgery, 152, 1165–1171. doi:10.1016/j.surg.2012.08.056
  • Okosieme, O. E., Belludi, G., Spittle, K., Kadiyala, R., & Richards, J. (2011). Adequacy of thyroid hormone replacement in a general population. QJM, 104, 395–401. doi:10.1093/qjmed/hcq222
  • Pacini, F., Castagna, M. G., Brilli, L., Pentheroudakis, G., & ESMO Guidelines Working Group. (2010). Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 21, v214–219. doi:10.1093/annonc/mdq190
  • Ruddy, K., Mayer, E., & Partridge, A. (2009). Patient adherence and persistence with oral anticancer treatment. CA: A Cancer Journal for Clinicians, 59(1), 56–66. doi:10.3322/caac.20004
  • Sabaté, E., & World Health Organization. (2003). Adherence to long-term therapies: Evidence for action. Switzerland: World Health Organization.
  • Sangha, O., Stucki, G., Liang, M. H., Fossel, A. H., & Katz, J. N. (2003). The self-administered comorbidity questionnaire: A new method to assess comorbidity for clinical and health services research. Arthritis & Rheumatology, 49, 156–163. doi:10.1002/art.10993
  • UICC: TNM Atlas Illustrated Guide to the TNM/pTNM Classification of Malignant Tumors. (1992) (4th ed., 2nd Revision ed., pp. 141–144). Berlin: Springer-Verlag.
  • van de Ven, M. O., Witteman, C. L., & Tiggelman, D. (2013). Effect of Type D personality on medication adherence in early adolescents with asthma. Journal of Psychosomatic Research, 75, 572–576. doi:10.1016/j.jpsychores.2013.09.001
  • Verbrugghe, M., Verhaeghe, S., Lauwaert, K., Beeckman, D., & Van Hecke, A. (2013). Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: A systematic review. Cancer Treatment Reviews, 39, 610–621. doi:10.1016/j.ctrv.2012.12.014
  • Vermeire, E., Hearnshaw, H., Van Royen, P., & Denekens, J. (2001). Patient adherence to treatment: Three decades of research. A comprehensive review. Journal of Clinical Pharmacy and Therapeutics, 26, 331–342. doi:10.1046/j.1365-2710.2001.00363.x
  • Williams, L., O'Connor, R. C., Grubb, N., & O'Carroll, R. (2011). Type D personality predicts poor medication adherence in myocardial infarction patients. Psychology & Health, 26, 703–712. doi:10.1080/08870446.2010.488265
  • Wu, J. R., & Moser, D. K. (2014). Type D personality predicts poor medication adherence in patients with heart failure in the USA. International Journal of Behavioral Medicine, 21, 833–842. doi:10.1007/s12529-013-9366-2